+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Development of resistance to aminoglycosides among coagulase-negative staphylococci and enterobacteriaceae in a neonatal intensive care unit



Development of resistance to aminoglycosides among coagulase-negative staphylococci and enterobacteriaceae in a neonatal intensive care unit



Journal Of Hospital Infection. 24(1): 39-46



A prospective study of the development of resistance to aminoglycosides among coagulase-negative staphylococci (CNS) and Enterobacteriaceae (ENT) was conducted for all patients admitted to a neonatal intensive care unit (NICU) from October 1985 to January 1990. A change in antibiotic regimen from gentamicin to amikacin occurred in January 1986, due to widespread gentamicin resistance among CNS, the most important cause of nosocomial infections in this NICU. From 657 patients, 884 faecal cultures, 1505 cultures from the respiratory tract and 152 blood cultures were included in the study. After its introduction, susceptibility to amikacin decreased rapidly in faecal and respiratory CNS isolates (from 62% to 28% and from 58% to 23% respectively). During the first half year, resistance to amikacin in faecal CNS isolates developed more rapidly among antibiotic-treated patients than among patients not treated with antibiotics. Susceptibility to amikacin in CNS blood isolates decreased more slowly, from 94% to 58% in 1987, while subsequently an increase in susceptibility was observed to about 80% in 1989. The same difference in development of resistance in faecal and respiratory CNS isolates compared to CNS blood isolates was noticed for gentamicin and tobramycin. In contrast, ENT remained highly (85-100%) susceptible to amikacin, gentamicin and tobramycin throughout the study period. It was concluded that four years after its introduciton amikacin still appeared to be a valuable antibiotic in combination treatment of the vast majority of clinically important infections occurring in our NICU, since both Enterobacteriaceae and the majority of CNS blood isolates proved to be susceptible to this agent. However, no substantial advantage in terms of susceptibility was found in the use of amikacin over gentamicin or tobramycin.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008454841

Download citation: RISBibTeXText

PMID: 8101201

DOI: 10.1016/0195-6701(93)90088-h


Related references

Phenotypic and genotypic aminoglycoside resistance in blood culture isolates of coagulase-negative staphylococci from a single neonatal intensive care unit, 1989-2000. Journal of Antimicrobial ChemoTherapy 54(5): 889-896, 2004

Coagulase Negative Staphylococci in the Neonatal Intensive Care Unit Are We Any Smarter?. NeoReviews 14(6): e284-e293, 2013

Septicemia due to coagulase-negative staphylococci in a neonatal intensive care unit. Pediatric Infectious Disease Journal 2(6): 426-431, 1983

Relationship of characteristics of coagulase negative staphylococci with neonatal bacteremia in the neonatal intensive care unit. Clinical Research 34(4): 979A, 1986

Incidence and antibiotic resistance of coagulase-negative staphylococci in a neonatal intensive are unit. Ginekologia Polska 65(7): 368-371, 1994

A decrease in resistance to beta-lactam antibiotics among coagulase-negative staphylococci blood isolates in a neonatal intensive care unit following a reduction in antibiotic consumption A causal relationship?. Pediatric Research 49(4 Part 2): 236A, April, 2001

Molecular epidemiology of coagulase negative staphylococci in a neonatal intensive care unit. Pediatric Research 27(4 PART 2): 268A, 1990

Healthcare associated infections caused by coagulase-negative Staphylococci in a neonatal intensive care unit. Revista Brasileira de Terapia Intensiva 25(3): 239-244, 2015

Bacteremia due to persistent strains of coagulase-negative staphylococci in a neonatal intensive-care unit. Infection Control and Hospital Epidemiology 20(5): 349-351, 1999

Endemic strains of coagulase negative staphylococci causing bacteremia in a neonatal intensive care unit. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 37: 319, 1997

Molecular characterization of bloodstream isolates of coagulase negative staphylococci in a neonatal intensive care unit. Abstracts of the General Meeting of the American Society for Microbiology 92: 452, 1992

Molecular characterization of methicillin-resistant coagulase-negative staphylococci from a neonatal intensive care unit. Infection Control and Hospital Epidemiology 23(8): 447-451, 2002

The ica operon and biofilm production in coagulase-negative staphylococci associated with carriage and disease in a neonatal intensive care unit. Journal of Clinical Microbiology 40(2): 382-388, 2002

Late onset sepsis: comparison between coagulase-negative staphylococci and other bacteria in the neonatal intensive care unit. Infectious Diseases: 1-7, 2018

Detection and molecular characterization of endemic strains of coagulase negative staphylococci cns in a neonatal intensive care unit. Abstracts of the General Meeting of the American Society for Microbiology 92: 452, 1992